Karen Zakalik

A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis

B. Weinstock-Guttman, D. Jakimovski, S. Eckert, 2022, Multiple sclerosis journal - experimental, translational and clinical.

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

B. Weinstock-Guttman, D. Jakimovski, S. Eckert, 2022, Vaccines.

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

M. Benatar, M. Bromberg, M. Pasnoor, 2020, JAMA neurology.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

P. van Damme, M. Benatar, F. Piehl, 2019, Journal of the Neurological Sciences.

Parity Associated with Long-Term Disease Progression in Women with Multiple Sclerosis (P02.130)

B. Weinstock-Guttman, C. Kolb, K. Kavak, 2013 .

Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC)

T. Coetzee, R. Zivadinov, B. Weinstock-Guttman, 2022, Multiple sclerosis.

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

P. van Damme, M. Benatar, F. Piehl, 2020, Journal of Neurology.

Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset

B. Weinstock-Guttman, J. Hagemeier, K. Kavak, 2015, Multiple sclerosis.